(Q51356695)

4 April 2018

title

Evaluation of oxidative stress in overweight subjects with or without metabolic syndrome. (English)

1 reference

4 April 2018

0 references

1 reference

Danielle Venturini

1

1 reference

4 April 2018

Andréa N C Simão

2

1 reference

4 April 2018

Nicole A Scripes

3

1 reference

4 April 2018

Larissa D Bahls

4

1 reference

4 April 2018

Petrônio A S Melo

5

1 reference

4 April 2018

Francine M Belinetti

6

1 reference

4 April 2018

Marcell A B Lozovoy

7

1 reference

4 April 2018

Isaias Dichi

8

1 reference

4 April 2018

publication date

17 May 2012

1 reference

4 April 2018

published in

Obesity

1 reference

4 April 2018

volume

20

1 reference

4 April 2018

issue

12

1 reference

4 April 2018

page(s)

2361-2366

1 reference

4 April 2018

Banting lecture 1988. Role of insulin resistance in human disease

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Metabolic syndrome pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

The relationship between body mass index and a plasma lipid peroxidation biomarker in an older, healthy Asian community

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Oxidative stress is associated with adiposity and insulin resistance in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Oxidative stress markers in Korean subjects with insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Increased oxidative stress in obesity and its impact on metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Advanced oxidation protein products (AOPPs) in juvenile overweight and obesity prior to and following weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Insulin resistance, inflammation, and the prediabetic state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Free radical-mediated pre-hemolytic injury in human red blood cells subjected to lead acetate as evaluated by chemiluminescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Metabolic syndrome and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Uric Acid Levels Are Associated With All-Cause and Cardiovascular Disease Mortality Independent of Systemic Inflammation in Men From the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Cardiovascular morbidity and mortality associated with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Hydroperoxide-initiated chemiluminescence: An assay for oxidative stress in biopsies of heart, liver, and muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Advanced oxidation protein products as a novel marker of oxidative stress in uremia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Oxidative stress in blood of HIV infected patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Oxidative stress and glycemic regulation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Nitric oxide enhancement and blood pressure decrease in patients with metabolic syndrome using soy protein or fish oil

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

Banting lecture 1988. Role of insulin resistance in human disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.130

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2012.130

1 reference

4 April 2018

1 reference

4 April 2018